| 614 |
FDA Guidance for Industry(draft): Delaying, Denying, Limiting, or Refusing Inspection |
2023-01-13 |
| 613 |
Contamination Control Strategy Guideline |
2022-12-21 |
| 612 |
IPEC-PQG GMP for Excipients |
2022-12-17 |
| 611 |
OECD의 GLP분야 Data Integrity Guidelines |
2022-11-19 |
| 610 |
EU GMP 등 개정 계획 |
2022-09-05 |
| 609 |
EU_Volume 4. Annex 1: Manufacture of Sterile Medicinal Products |
2022-08-26 |
| 608 |
FDA: Conducting Remote Regulatory Assessments(RRAs) Q&A |
2022-08-05 |
| 607 |
정말로 FDA승인을 받은 제품인가? |
2022-07-13 |
| 606 |
EMA: Overview of Comments on ICH Q9(R1) 발표 |
2022-05-04 |
| 605 |
FDA: Microbiological Quality Considerations in Non-sterile Drug Manufacturing(draft) 발표 |
2021-10-08 |
